Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Audibert

Showing results (11-20 of 164) with videos related to

Pageof 17
Sort By:
Progress in Clinical and Biological Research|January 1, 1980
Recent advances concerning the use of muramyl dipeptide derivatives as vaccine potentiatorsF Audibert, L Chedid
Infection and Immunity|December 1, 1976
Activity in saline of phthalylated or succinylated derivatives of mycobacterial water-soluble adjuvantF Audibert, L Chedid
Springer Seminars in Immunopathology|January 1, 1985
New approaches for control of infections using synthetic or semi-synthetic constructs containing MDPL Chedid, F Audibert
Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles|April 7, 1975
[Increase of immune response by administration of metabolizable vegetable oil emulsions]F Audibert, L Chedid
The Journal of Infectious Diseases|August 1, 1977
Chemically defined bacterial products with immunopotentiating activityL Chedid, F Audibert
Agents and Actions|February 1, 1976
Adjuvant disease induced by mycobacteria, determinants of arthritogenicityF Audibert, L Chedid
Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles|March 16, 1970
[2 physiological functions of humoral immunity and the 2 proteins which assume it in the horse serum]G Sandor, F Audibert
Annales De L'Institut Pasteur|February 1, 1972
[Study of the major antitoxin of equine serums (IgT), in relation to other immunoglobulins present in these serums]F Audibert, G Sandor
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|June 23, 2009
[Management of severe fetal disease without TOP: Canadian experience]C Le Ray, F Audibert
Current Opinion in Immunology|December 1, 1989
Immunoadjuvants and analogs of immunomodulatory bacterial structuresL D Lise, F Audibert
Pageof 17

Showing results (11-20 of 164) with videos related to

Sort By:
Pageof 17
Progress in Clinical and Biological Research|January 1, 1980
Recent advances concerning the use of muramyl dipeptide derivatives as vaccine potentiatorsF Audibert, L Chedid
Infection and Immunity|December 1, 1976
Activity in saline of phthalylated or succinylated derivatives of mycobacterial water-soluble adjuvantF Audibert, L Chedid
Springer Seminars in Immunopathology|January 1, 1985
New approaches for control of infections using synthetic or semi-synthetic constructs containing MDPL Chedid, F Audibert
Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles|April 7, 1975
[Increase of immune response by administration of metabolizable vegetable oil emulsions]F Audibert, L Chedid
The Journal of Infectious Diseases|August 1, 1977
Chemically defined bacterial products with immunopotentiating activityL Chedid, F Audibert
Agents and Actions|February 1, 1976
Adjuvant disease induced by mycobacteria, determinants of arthritogenicityF Audibert, L Chedid
Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles|March 16, 1970
[2 physiological functions of humoral immunity and the 2 proteins which assume it in the horse serum]G Sandor, F Audibert
Annales De L'Institut Pasteur|February 1, 1972
[Study of the major antitoxin of equine serums (IgT), in relation to other immunoglobulins present in these serums]F Audibert, G Sandor
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|June 23, 2009
[Management of severe fetal disease without TOP: Canadian experience]C Le Ray, F Audibert
Current Opinion in Immunology|December 1, 1989
Immunoadjuvants and analogs of immunomodulatory bacterial structuresL D Lise, F Audibert
Pageof 17